JPS6217966B2 - - Google Patents
Info
- Publication number
- JPS6217966B2 JPS6217966B2 JP22860382A JP22860382A JPS6217966B2 JP S6217966 B2 JPS6217966 B2 JP S6217966B2 JP 22860382 A JP22860382 A JP 22860382A JP 22860382 A JP22860382 A JP 22860382A JP S6217966 B2 JPS6217966 B2 JP S6217966B2
- Authority
- JP
- Japan
- Prior art keywords
- mol
- sodium
- moles
- hydrogenated castor
- poe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 47
- 239000004359 castor oil Substances 0.000 claims description 46
- 235000019438 castor oil Nutrition 0.000 claims description 43
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 43
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 33
- 239000011780 sodium chloride Substances 0.000 claims description 21
- -1 polyoxyethylene Polymers 0.000 claims description 20
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 239000004711 α-olefin Substances 0.000 claims description 7
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 2
- 239000000606 toothpaste Substances 0.000 description 36
- 229940034610 toothpaste Drugs 0.000 description 34
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 32
- 239000003205 fragrance Substances 0.000 description 24
- 239000007788 liquid Substances 0.000 description 21
- 238000000926 separation method Methods 0.000 description 20
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 16
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 16
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 16
- 239000011734 sodium Substances 0.000 description 16
- 229910052708 sodium Inorganic materials 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000012190 activator Substances 0.000 description 15
- 125000000129 anionic group Chemical group 0.000 description 15
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 15
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 13
- 238000005187 foaming Methods 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 description 10
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 10
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 description 8
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 6
- 206010013911 Dysgeusia Diseases 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 6
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 244000246386 Mentha pulegium Species 0.000 description 4
- 235000016257 Mentha pulegium Nutrition 0.000 description 4
- 235000004357 Mentha x piperita Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 235000001050 hortel pimenta Nutrition 0.000 description 4
- 229960000401 tranexamic acid Drugs 0.000 description 4
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 3
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 description 3
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 3
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 3
- 229960003720 enoxolone Drugs 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 125000005313 fatty acid group Chemical group 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- 239000001683 mentha spicata herb oil Substances 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 235000019721 spearmint oil Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 239000005973 Carvone Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- KXSLJPFXTIACAG-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na] Chemical compound [Na].[Na].[Na].[Na].[Na] KXSLJPFXTIACAG-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Description
本発明は、平均エチレンオキシド付加モル数が
50モル以下のポリオキシエチレン硬化ヒマシ油と
アニオン活性剤とを併用してなる口腔用組成物に
関する。
練歯磨等の口腔用組成物には、通常発泡剤とし
てラウリル硫酸ナトリウム等のアニオン活性剤が
配合されており、これは香料などの分散剤として
の機能をも有している。しかし、ラウリル硫酸ナ
トリウム等のアニオン活性剤のみでは香料、特に
極性の低い香料成分や油性分の可溶化力が少な
い。即ち、多くの香料は親油性で、特に天然精油
に含まれる炭化水素系の成分は親水性が弱く、ア
ニオン活性剤のみではこれらの香料を十分に溶解
分散させることが困難である。このため、従来よ
り口腔用組成物の香料として広く用いられている
ペパーミント油やスペアミント油は水に難溶性の
モノテルペンを多く含み、これを多量に用いた場
合はアニオン活性剤のみで可溶化することが困難
で、その使用量に限度が生じるので、比較的親水
性のあるメントールやカルボンを補助的に添加
し、香味が低下することを防止している。また、
色素、油溶性ビタミン等の油溶性成分も同様にア
ニオン活性剤のみでは十分に溶解分散しない。従
つて、これら香料、油溶性成分の分散、可溶化を
容易にするため、口腔用組成物の可溶化力を更に
高めることが望まれる。
また、練歯磨等の口腔用組成物は、商品価値の
上から保存安定性が高く、保存中に液分離が生じ
ないことが必要であり、更にチユーブからの押出
し性が良好で、低温下に長期間保存した後でもチ
ユーブからスムーズに押し出されるものであるこ
とも重要な特性であり、また口腔用組成物は口腔
内で使用するものであるから、使用感が良好であ
ることが望まれる。
本発明者らは、上記事情に鑑み、香料や油溶性
成分などの分散可溶化力に優れ、かつ保存安定性
が良好で液分離が生じ難く、しかも使用感に優れ
た口腔用組成物につき鋭意研究を行なつた結果、
平均エチレンオキシド付加モル数が50モル以下の
ポリオキシエチレン硬化ヒマシ油とアニオン活性
剤とを併用する場合に上記目的が効果的に達成さ
れることを知見した。
即ち、従来より平均エチレンオキシド付加モル
数が60モルのポリオキシエチレン硬化ヒマシ油
(以下、POE(60モル)硬化ヒマシ油と記載す
る)をアシルアミノ酸やラウリル硫酸ナトリウム
といつたアニオン活性剤と併用すること、更には
これに塩化ナトリウムを配合することは公知であ
る(特公昭55−6611号、特開昭54−20142、54−
59340、56−113709、57−106606号)。しかし、本
発明者らが検討した結果では、POE(60モル)
硬化ヒマシ油をアニオン活性剤と併用した口腔用
組成物は液分離が生じ易く、とりわけ塩化ナトリ
ウム未配合の系においては液分離が著しくて使用
に耐えず、商品価値を損うものであつた。また、
POE(60モル)硬化ヒマシ油をアニオン活性剤
と併用した場合、特に塩化ナトリウム配合系にあ
つては、使用感、とりわけあと味が悪く、起泡速
度も十分でなく、また低温における押出し性に劣
り、低温で長期保存した場合、チユーブからの押
出し易さが低下するものであつた。
ところが、平均エチレンオキシド(EO)付加
モル数が50モル、40モル、30モル、20モル及び10
モルのポリオキシエチレン硬化ヒマシ油から選ば
れる少なくとも1種を組成物全体の0.1〜3重量
%と、アルキル基の炭素数8〜18の高級アルキル
硫酸エステルの水溶性塩及び/又はα−オレフイ
ンスルフオン酸の水溶性塩を組成物全体の0.5〜
5重量%とを併用した場合、意外にも上述したよ
うなPOE(60モル)硬化ヒマシ油を用いた場合
に生じる欠点が解決され、液分離が生じ難く、か
つ低温でのチユーブからの押出し性が良好で、低
温下に長期間保存した後においてもチユーブから
スムーズに押し出され、かつあと味が良好で起泡
速度も早く、使用感に優れ、しかも香料や油溶性
成分の分散性が良好な口腔用組成物が得られるこ
とを知見し、本発明をなすに至つたものである。
以下、本発明につき更に詳しく説明する。
本発明に係る口腔用組成物は、平均エチレンオ
キシド(EO)付加モル数が50モル、40モル、30
モル、20モル及び10モルのポリオキシエチレン
(POE)硬化ヒマシ油から選ばれる少なくとも1
種を組成物全体の0.1〜3重量%含有していると
共に、ラウリル硫酸ナトリウム、ミリスチル硫酸
ナトリウム等のアルキル基の炭素数8〜18の高級
アルキル硫酸エステルの水溶性塩及び/又はα−
オレフインスルフオン酸の水溶性塩(例えばナト
リウム塩)を組成物全体の0.5〜5重量%含有し
てなるものである。
なお、上記の平均EO付加モル数が50モル以下
のPOE硬化ヒマシ油の中では、平均EO付加モル
数20モル及び40モルのPOE硬化ヒマシ油が好適
に用いられる。
また、本発明おいては、必要により更に他のア
ニオン活性剤、例えば、ソジウムラウリルモノグ
リセライドスルホネート、ソジウムココナツツモ
ノグリセライドスルホネート等の脂肪酸基の炭素
数が10〜18である高級脂肪酸モノグリセライドス
ルホネートの水溶性塩、高級脂肪酸ソジウムモノ
グリセライドモノサルフエート、ソジウム−N−
メチル−N−パルミトイルタウライド、ソジウム
−N−ラウロイルザルコシネート、ソジウム−N
−ラウロイル−β−アラニン等の脂肪酸基の炭素
数が12〜18である高級脂肪酸と低級脂肪族アミノ
酸とのアマイドの塩などを配合することもでき
る。
本発明の口腔用組成物は、上述したように平均
EO付加モル数50モル以下のPOE硬化ヒマシ油と
アニオン活性剤とを併用していることにより、液
分離が生じ難く、特に塩化ナトリウムを配合して
いない系においても、POE(60モル)硬化ヒマ
シ油を用いた場合のように著しく液分離が生じる
という不都合がないものであり、このため塩化ナ
トリウム未配合系において好適に用いられるもの
であるが、本発明口腔用組成物中に塩化ナトリウ
ムを配合しても支障がなく、塩化ナトリウム配合
系において用いても、低温押出し性が良好であ
り、またあと味が良く、発泡性も良好で使用感に
優れたものであり、従つて塩化ナトリウム配合系
にも好適に使用されるものである。
なお、塩化ナトリウムを配合する場合、その配
合量は組成物全体の3〜30%とすることが好まし
い。3%より少ないと塩化ナトリウム配合のメリ
ツトが十分発揮されず、特に塩味が十分付与され
ない。また、30%より多いと使用感の低下を招く
場合がある。
また、本発明の口腔用組成物は、平均EO付加
モル数50モル以下のPOE硬化ヒマシ油とアニオ
ン活性剤とを併用していることにより、香料や油
溶性成分の分散性が良く、このため、香料、特に
ペパーミント油、スペアミント油等のモノテルペ
ンを多く含むもの、親油性のものをその可溶分散
力を高めて多量に用いることができ、また色素、
油溶性ビタミン等の油溶性成分をも分散性良く配
合し得る。
なお、本発明において好適に用いられる香料を
例示すると、ペパーミント油、スペアミント油の
ほか、メントール、カルボン、アネトール、オイ
ゲノール、サリチル酸メチル、リモネン、オシメ
ン、n−デシルアルコール、シトロネロール、α
−テルピネオール、メチルアセテート、シトロネ
リルアセテート、メチルオイゲノール、シネオー
ル、リナロール、エチルリナロール、ワニリン、
チモール、レモン油、オレンジ油、セージ油、ロ
ーズマリー油、桂皮油、ピメント油、桂葉油、シ
ソ油、冬緑油、丁子油、ユーカリ油等が挙げら
れ、本発明においてはこれらの香料を単独で又は
組合せて全体の0.1〜10%、好ましくは0.5〜5%
程度配合し得る。
本発明の口腔用組成物は、練歯磨等の歯磨類な
どとして適用されるもので、本発明においては更
にその口腔用組成物の種類等に応じて通常使用さ
れる適宜な成分が配合され得る。
例えば、歯磨類の場合には、第2リン酸カルシ
ウム・2水和物及び無水物、第1リン酸カルシウ
ム、第3リン酸カルシウム、炭酸カルシウム、ピ
ロリン酸カルシウム、水酸化アルミニウム、アル
ミナ、無水ケイ酸、シリカゲル、ケイ酸アルミニ
ウム、不溶性メタリン酸ナトリウム、第3リン酸
マグネシウム、炭酸マグネシウム、硫酸カルシウ
ム、ポリメタクリル酸メチル、ベントナイト、ケ
イ酸ジルコニウム、合成樹脂等の1種又は2種以
上を配合し得る(配合量通常20〜60%)。
また、練歯磨等のペースト状組成物の場合には
粘結剤としてカラゲナン、カルボキシメチルセル
ロースナトリウム、メチルセルロース、ヒドロキ
シエチルセルロース、ヒドロキシプロピルセルロ
ース、カルボキシメチルヒドロキシエチルセルロ
ースナトリウムなどのセルロース誘導体、アルギ
ン酸ナトリウムなどのアルカリ金属アルギネー
ト、アルギン酸プロピレングリコールエステル、
キサンタンガム、トランガカントガム、カラヤガ
ム、アラビヤガムなどのガム類、ポリビニルアル
コール、ポリアクリル酸ナトリウム、カルボキシ
ビニルポリマー、ポリビニルピロリドンなどの合
成粘結剤、シリカゲル、アルミニウムシリカゲ
ル、ビーガム、ラポナイトなどの無機粘結剤等の
1種又は2種以上が配合され得る(配合量通常
0.3〜5%)。
更に、歯磨類等のペースト状や液状口腔用組成
物の製造において、粘稠剤としてソルビツト、グ
リセリン、エチレングリコール、プロピレングリ
コール、1・3−ブチレングリコール、ポリエチ
レングリコール(#400〜#4000)、ポリプロピレ
ングリコール、キシリツト、マルチツト、ラクチ
ツト等の1種又は2種以上を配合し得る(配合量
通常10〜70%)。
また更に、本発明においては平均EO付加モル
数50モル以下のPOE硬化ヒマシ油、アニオン活
性剤に加えて、必要により他の界面活性剤、例え
ばラウリン酸モノ又はジエタノールアミド等の脂
肪酸モノ又はジエタノールアミド、ステアリルモ
ノグリセライド、シヨ糖モノ及びジラウレート等
の脂肪酸基の炭素数が12〜18であるシヨ糖脂肪酸
エステル、ラクトース脂肪酸エステル、ラクチト
ール脂肪酸エステル、マルチトール脂肪酸エステ
ル、ステアリン酸モノグリセライド、ポリオキシ
エチレンソルビタンモノラウレート、エチレング
リコール約60モルが付加したソルビタンモノステ
アレート縮合物、エチレンオキサイドとプロピレ
ンオキサイドの重合物及びポリオキシエチレンポ
リオキシプロピレンモノラウリルエステル等の誘
導体といつた非イオン活性剤などの1種又は2種
以上を配合しても差支えない。この場合、POE
(60モル)硬化ヒマシ油も本発明の効果を損なわ
ない範囲で使用でき、更に平均EO付加モル数が
60モルより多いもの、例えばPOE(80モル又は
100モル)硬化ヒマシ油を使用することができ
る。
本発明の口腔用組成物には、更にサツカリンナ
トリウム、ステビオサイド、ネオヘスペリジルジ
ヒドロカルコン、グリチルリチン、ペリラルチ
ン、タウマテン、アスパラチルフエニルアラニン
メチルエステル、p−メトキシシンナミツクアル
デヒドなどの甘味剤(0〜1%、好ましくは0.01
〜0.5%)、p−ヒドロキシメチルベンゾイツクア
シド、p−ヒドロキシエチルベンゾイツクアシ
ド、p−ヒドロキシプロピルベンゾイツクアシ
ド、p−ヒドロキシブチルベンゾイツクアシド、
安息香酸ナトリウム、低級脂肪酸モノグリセライ
ドなどの防腐剤、ゼラチン、ペプトン、アルギニ
ン塩酸塩、アルブミン、カゼイン、二酸化チタ
ン、その他の成分を配合し得る。
なおまた、本発明においては、有効成分とし
て、デキストラナーゼ、アミラーゼ、プロテアー
ゼ、ムタナーゼ、リゾチーム、溶菌酵素、リテツ
クエンザイム等の酵素、モノフルオロリン酸ナト
リウム、モノフルオロリン酸カリウムなどのアル
カリ金属モノフルオロホスフエート、フツ化ナト
リウム、フツ化第1錫等のフツ化物、トラネキサ
ム酸やイプシロンアミノカプロン酸、クロルヘキ
シジン塩酸塩、クロルヘキシジングルコン酸塩、
トコフエロール、アルミニウムクロルヒドロキシ
ルアラントイン、ジヒドロコレステロール、グリ
チルリチン酸、グリチルリチンジカリウム、グリ
チルレチン酸、グリセロホスフエート、クロロフ
イル、銅クロロフイリンナトリウム、カロペプタ
イド、水溶性無機リン酸化合物、アズレン、カミ
ツレ、当帰、芍薬、川〓、生姜、莪述などの生薬
類等の有効成分を1種又は2種以上配合し得るも
のである。
次に実験例を示し、本発明の効果を具体的に説
明する。
実施例 1
第2リン酸カルシウム・2水塩5%と第1表に
示す界面活性剤を所定濃度で配合した試料溶液50
mlに対し油溶性色素yellowABを0.01g添加し、
ケミカルスターラーで撹拌(400rpm、1分間)
した後、直ちに過して未溶解分を除去し、液
の吸光度を測定した(層長10mm、波長450nm)。
その結果を第1表に示す。
In the present invention, the average number of moles of ethylene oxide added is
The present invention relates to an oral composition comprising 50 moles or less of polyoxyethylene hydrogenated castor oil in combination with an anionic activator. Oral compositions such as toothpaste usually contain an anionic active agent such as sodium lauryl sulfate as a foaming agent, which also functions as a dispersant for fragrances and the like. However, the use of only an anionic activator such as sodium lauryl sulfate has little ability to solubilize perfumes, particularly low polar perfume components and oily components. That is, many fragrances are lipophilic, and in particular, hydrocarbon components contained in natural essential oils have weak hydrophilicity, and it is difficult to sufficiently dissolve and disperse these fragrances using anionic activators alone. For this reason, peppermint oil and spearmint oil, which have traditionally been widely used as flavoring agents in oral compositions, contain a large amount of monoterpenes that are poorly soluble in water, and when used in large amounts, they can be solubilized only by the anionic activator. Since it is difficult to do this and there is a limit to the amount of menthol that can be used, comparatively hydrophilic menthol and carvone are added as supplements to prevent the flavor from deteriorating. Also,
Similarly, oil-soluble components such as pigments and oil-soluble vitamins are not sufficiently dissolved and dispersed using anionic activators alone. Therefore, in order to facilitate the dispersion and solubilization of these fragrances and oil-soluble components, it is desirable to further enhance the solubilizing power of oral compositions. In addition, from the viewpoint of commercial value, oral compositions such as toothpaste must have high storage stability and no liquid separation during storage. Furthermore, they must be extrudable from tubes and can be stored at low temperatures. Another important property is that it can be extruded smoothly from the tube even after long-term storage, and since oral compositions are used in the oral cavity, it is desirable that they have a good feel when used. In view of the above circumstances, the present inventors have made efforts to develop an oral composition that has excellent ability to disperse and solubilize fragrances and oil-soluble ingredients, has good storage stability, is resistant to liquid separation, and is comfortable to use. As a result of research,
It has been found that the above object can be effectively achieved when polyoxyethylene hydrogenated castor oil having an average number of added moles of ethylene oxide of 50 moles or less is used in combination with an anionic activator. That is, conventionally, polyoxyethylene hydrogenated castor oil (hereinafter referred to as POE (60 moles) hydrogenated castor oil) with an average number of moles of ethylene oxide added of 60 moles is used in combination with anionic activators such as acylamino acids and sodium lauryl sulfate. In addition, it is known that sodium chloride is added to this (Japanese Patent Publication No. 55-6611, JP-A No. 54-20142, 54-
59340, 56-113709, 57-106606). However, according to the results of the study by the present inventors, POE (60 mol)
Oral compositions containing hydrogenated castor oil in combination with an anionic activator are prone to liquid separation, and especially in systems that do not contain sodium chloride, liquid separation is so severe that they are unusable and impair commercial value. Also,
When POE (60 mol) hydrogenated castor oil is used in combination with an anionic activator, especially in systems containing sodium chloride, the feeling of use is poor, especially aftertaste, the foaming rate is insufficient, and the extrudability at low temperatures is poor. When stored at low temperatures for a long period of time, the ease of extrusion from the tube was reduced. However, when the average number of moles of ethylene oxide (EO) added was 50 moles, 40 moles, 30 moles, 20 moles, and 10 moles,
0.1 to 3% by weight of the entire composition of at least one selected from polyoxyethylene hydrogenated castor oil, and a water-soluble salt of a higher alkyl sulfate having an alkyl group of 8 to 18 carbon atoms and/or an α-olefin sulfate. Add water-soluble salt of fonic acid to 0.5 to 0.5% of the total composition
When POE (60 mol) is used in combination with 5% by weight, the drawbacks that occur when using POE (60 mol) hydrogenated castor oil are surprisingly solved, liquid separation is less likely to occur, and extrusion from the tube at low temperatures is improved. It has good properties, is extruded smoothly from the tube even after long-term storage at low temperatures, has a good aftertaste, has a fast foaming rate, is easy to use, and has good dispersibility of fragrances and oil-soluble ingredients. The present invention was based on the discovery that oral compositions can be obtained. The present invention will be explained in more detail below. The oral composition according to the present invention has an average number of added moles of ethylene oxide (EO) of 50 moles, 40 moles, and 30 moles.
at least one selected from polyoxyethylene (POE) hydrogenated castor oil, mol, 20 mol and 10 mol.
Contains 0.1 to 3% by weight of seeds based on the total composition, and water-soluble salts and/or α-
The composition contains a water-soluble salt (for example, sodium salt) of olefin sulfonic acid in an amount of 0.5 to 5% by weight based on the total composition. Note that among the POE hydrogenated castor oils having an average number of EO added moles of 50 moles or less, POE hydrogenated castor oils having an average number of EO added moles of 20 and 40 moles are preferably used. In addition, in the present invention, if necessary, other anionic activators may be used, such as water-soluble higher fatty acid monoglyceride sulfonates whose fatty acid group has 10 to 18 carbon atoms, such as sodium lauryl monoglyceride sulfonate and sodium coconut monoglyceride sulfonate. higher fatty acid sodium monoglyceride monosulfate, sodium N-
Methyl-N-palmitoyl tauride, Sodium-N-lauroyl sarcosinate, Sodium-N
A salt of an amide of a higher fatty acid having a fatty acid group having 12 to 18 carbon atoms such as -lauroyl-β-alanine and a lower aliphatic amino acid can also be blended. The oral composition of the present invention has an average
By using POE hydrogenated castor oil with an EO addition mole of 50 moles or less and an anionic activator, liquid separation is difficult to occur, and even in systems that do not contain sodium chloride, POE (60 moles) hydrogenated castor oil It does not have the disadvantage of significant liquid separation that occurs when oil is used, and is therefore suitable for use in systems that do not contain sodium chloride. Even when used in sodium chloride-containing systems, it has good low-temperature extrudability, has a good aftertaste, has good foaming properties, and has an excellent feel when used. It is also suitably used. In addition, when blending sodium chloride, the blending amount is preferably 3 to 30% of the total composition. If the amount is less than 3%, the benefits of adding sodium chloride will not be fully exhibited, and in particular, the salty taste will not be imparted sufficiently. Moreover, if it is more than 30%, the usability may deteriorate. In addition, the oral composition of the present invention has good dispersibility of fragrances and oil-soluble components due to the combined use of POE hydrogenated castor oil with an average number of added moles of EO of 50 moles or less and an anionic activator. , fragrances, especially those containing a large amount of monoterpenes such as peppermint oil and spearmint oil, and lipophilic ones can be used in large amounts by increasing their solubility and dispersion ability, and pigments,
Oil-soluble ingredients such as oil-soluble vitamins can also be blended with good dispersibility. Incidentally, examples of fragrances suitably used in the present invention include peppermint oil, spearmint oil, menthol, carvone, anethole, eugenol, methyl salicylate, limonene, ocimene, n-decyl alcohol, citronellol, α
-Terpineol, methyl acetate, citronellyl acetate, methyleugenol, cineole, linalool, ethyllinalool, vanillin,
Examples include thymol, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, cinnamon leaf oil, perilla oil, wintergreen oil, clove oil, eucalyptus oil, etc. In the present invention, these fragrances are used alone. or in combination 0.1 to 10% of the total, preferably 0.5 to 5%
Can be mixed to some extent. The oral composition of the present invention is applied as a dentifrice such as a toothpaste, and in the present invention, appropriate commonly used ingredients may be further blended depending on the type of the oral composition. . For example, in the case of toothpaste, dibasic calcium phosphate dihydrate and anhydride, dibasic calcium phosphate, dibasic calcium phosphate, calcium carbonate, calcium pyrophosphate, aluminum hydroxide, alumina, silicic anhydride, silica gel, aluminum silicate , insoluble sodium metaphosphate, tertiary magnesium phosphate, magnesium carbonate, calcium sulfate, polymethyl methacrylate, bentonite, zirconium silicate, synthetic resin, etc. (compounding amount usually 20 to 60%). %). In addition, in the case of paste compositions such as toothpaste, cellulose derivatives such as carrageenan, sodium carboxymethylcellulose, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, sodium carboxymethylhydroxyethylcellulose, and alkali metal alginates such as sodium alginate are used as binders. , alginate propylene glycol ester,
Gums such as xanthan gum, trangacanth gum, karaya gum, and gum arabic, synthetic binders such as polyvinyl alcohol, sodium polyacrylate, carboxyvinyl polymer, and polyvinylpyrrolidone, and inorganic binders such as silica gel, aluminum silica gel, veegum, and laponite. One or more of these may be blended (the amount usually
0.3-5%). Furthermore, in the production of pasty or liquid oral compositions such as toothpaste, sorbitol, glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, polyethylene glycol (#400 to #4000), polypropylene are used as thickening agents. One or more of glycol, xyrite, maltite, lactite, etc. may be blended (the blending amount is usually 10 to 70%). Furthermore, in the present invention, in addition to POE hydrogenated castor oil having an average number of EO added moles of 50 moles or less and an anionic surfactant, other surfactants may be used as necessary, such as fatty acid mono- or diethanolamide such as lauric acid mono- or diethanolamide. , stearyl monoglyceride, sucrose fatty acid esters in which the fatty acid group has 12 to 18 carbon atoms such as sucrose mono- and dilaurate, lactose fatty acid ester, lactitol fatty acid ester, maltitol fatty acid ester, stearic acid monoglyceride, polyoxyethylene sorbitan monolaurate sorbitan monostearate condensate to which approximately 60 moles of ethylene glycol has been added, a polymer of ethylene oxide and propylene oxide, and a nonionic surfactant such as a derivative such as polyoxyethylene polyoxypropylene monolauryl ester; or There is no problem even if two or more types are blended. In this case, POE
(60 moles) Hydrogenated castor oil can also be used as long as it does not impair the effects of the present invention, and the average number of moles of EO added is
More than 60 moles, such as POE (80 moles or
100 mol) hydrogenated castor oil can be used. The oral composition of the present invention further contains sweeteners (from 0 to 1%, preferably 0.01
~0.5%), p-hydroxymethylbenzoitukaside, p-hydroxyethylbenzoitukaside, p-hydroxypropylbenzoitukaside, p-hydroxybutylbenzoitukaside,
Preservatives such as sodium benzoate and lower fatty acid monoglycerides, gelatin, peptone, arginine hydrochloride, albumin, casein, titanium dioxide, and other ingredients may be blended. Furthermore, in the present invention, the active ingredients include enzymes such as dextranase, amylase, protease, mutanase, lysozyme, lytic enzyme, and litetsu enzyme, and alkali metal monomers such as sodium monofluorophosphate and potassium monofluorophosphate. Fluorides such as fluorophosphate, sodium fluoride, and stannous fluoride, tranexamic acid and epsilon aminocaproic acid, chlorhexidine hydrochloride, chlorhexidine gluconate,
Tocopherol, aluminum chlorohydroxyallantoin, dihydrocholesterol, glycyrrhizinic acid, glycyrrhizin dipotassium, glycyrrhetinic acid, glycerophosphate, chlorophyll, sodium copper chlorophyllin, calopeptide, water-soluble inorganic phosphate compound, azulene, chamomile, toki, peony, river 〓 One or more kinds of active ingredients such as crude drugs such as , ginger, and soybeans can be blended. Next, experimental examples will be shown to specifically explain the effects of the present invention. Example 1 Sample solution 50 containing 5% dibasic calcium phosphate dihydrate and the surfactant shown in Table 1 at a predetermined concentration.
Add 0.01g of oil-soluble dye yellowAB per ml,
Stir with chemical stirrer (400 rpm, 1 minute)
After that, the solution was immediately filtered to remove undissolved components, and the absorbance of the solution was measured (layer length: 10 mm, wavelength: 450 nm). The results are shown in Table 1.
【表】
第1表の結果より、POE(40モル)硬化ヒマ
シ油をSDS(アニオン活性剤)と併用することに
よつてこれらが相乗的に作用し、油溶性成分を良
好に可溶化させることが認められた。
実験例 2
第2表に示す界面活性剤を用いた下記処方の練
歯磨を製造した。[Table] From the results in Table 1, by using POE (40 mol) hydrogenated castor oil together with SDS (anionic activator), these act synergistically and successfully solubilize oil-soluble components. was recognized. Experimental Example 2 A toothpaste with the following formulation was manufactured using the surfactants shown in Table 2.
【表】
次に、この練歯磨の液分離、泡立ちを下記方法
により評価した。結果を第2表に示す。
液分離
歯磨調製後、室温で1か月保存したときの液分
離を観察した。
〇:液分離なし
△:やや液分離あり
×:液分離あり
泡立ち
歯磨を実際に用いた場合の泡立ちを官能評価し
た。
〇:泡立ち良好
△:泡立ちやや少ない
×:殆んど泡立たない[Table] Next, the liquid separation and foaming of this toothpaste were evaluated using the following methods. The results are shown in Table 2. Liquid separation After preparing the toothpaste, liquid separation was observed when it was stored at room temperature for one month. ○: No liquid separation △: Slight liquid separation ×: Foaming with liquid separation A sensory evaluation of foaming was performed when the toothpaste was actually used. 〇: Good foaming △: Slightly low foaming ×: Almost no foaming
【表】
第2表の結果より、POE(60モル)硬化ヒマ
シ油をSDS(アニオン活性剤)と併用すると液分
離が生じるものであつたが、POE(50モル、40
モル、30モル、20モル及び10モル)硬化ヒマシ油
をアニオン活性剤と併用することによつて液分離
が生ぜずかつ泡立ちの良好な歯磨が得られること
が認められた。
実験例 3
下記処方の塩化ナトリウム配合練歯磨を製造
し、実験例2と同様にして液分離の有無を評価し
た。結果を第3表に示す。
炭酸カルシウム 40.0%
無水ケイ酸 2.0
プロピレングリコール 2.0
ソルビツト 16.0
カルボキシルメチルセルロースナトリウム 1.2
サツカリンナトリウム 0.1
SDS 1.5
POE硬化ヒマシ油 0.5
塩化ナトリウム 5.0
パラベン 0.1
香 料 1.0
精製水 残
100.0 [Table] From the results in Table 2, liquid separation occurred when POE (60 mol) hydrogenated castor oil was used in combination with SDS (anion activator), but POE (50 mol, 40 mol)
It was found that by using hydrogenated castor oil (mol, 30 mole, 20 mole, and 10 mole) in combination with an anionic activator, a toothpaste with good foaming properties without causing liquid separation could be obtained. Experimental Example 3 A sodium chloride-containing toothpaste having the following formulation was produced, and the presence or absence of liquid separation was evaluated in the same manner as in Experimental Example 2. The results are shown in Table 3. Calcium carbonate 40.0% Anhydrous silicic acid 2.0 Propylene glycol 2.0 Sorbit 16.0 Sodium carboxymethyl cellulose 1.2 Sodium satucalin 0.1 SDS 1.5 POE hydrogenated castor oil 0.5 Sodium chloride 5.0 Paraben 0.1 Fragrance 1.0 Purified water Balance 100.0
【表】
第3表の結果からもPOE(50モル、40モル、
30モル、20モル及び10モル)硬化ヒマシ油を用い
た場合に液分離が生じないものであることが認め
られた。
実験例 4
実験例3において製造した練歯磨において、
SDSの代わりに炭素数14のα−オレフインスルフ
オン酸ナトリウムを1.5%配合し、POE硬化ヒマ
シ油として平均EO付加モル数が60モル、40モ
ル、20モルのものを用いた以外は同処方の練歯磨
を製造し、実験例2と同様にして液分離の有無を
評価した。結果を第4表に示す。[Table] From the results in Table 3, POE (50 mol, 40 mol,
It was found that no liquid separation occurred when hydrogenated castor oil (30 mol, 20 mol, and 10 mol) was used. Experimental Example 4 In the toothpaste manufactured in Experimental Example 3,
The same formulation was used, except that 1.5% sodium α-olefin sulfonate having 14 carbon atoms was added instead of SDS, and POE hydrogenated castor oils with average EO addition moles of 60 mol, 40 mol, and 20 mol were used. A toothpaste was produced, and the presence or absence of liquid separation was evaluated in the same manner as in Experimental Example 2. The results are shown in Table 4.
【表】
第4表の結果からも、POE(20モル又は40モ
ル)硬化ヒマシ油とα−オレフインスルフオン酸
塩とを併用した場合に液分離が生じないものであ
ることが認められた。
実験例 5
下記処方の塩化ナトリウム配合練歯磨を製造
し、その使用感を評価した
炭酸カルシウム 40.0%
プロピレングリコール 2.0
ソルビツト 16.0
カルボキシメチルセルロースナトリウム 1.2
サツカリンナトリウム 0.05
SDS 2.0
POE硬化ヒマシ油 0.5
塩化ナトリウム 10.0
パラベン 0.1
香 料 1.0
精製水 残
100.0%
POE硬化ヒマシ油として平均EO付加モル数60
モルのものと50モル、40モル、30モル、20モル、
10モルのものとをそれぞれ用いた歯磨につき、専
門パネル10名による一対比較テストを行つた結果
を第5表に示す。[Table] From the results in Table 4, it was confirmed that liquid separation did not occur when POE (20 mol or 40 mol) hydrogenated castor oil and α-olefin sulfonate were used together. Experimental Example 5 A toothpaste containing sodium chloride with the following formulation was manufactured and its usability was evaluated. Calcium carbonate 40.0% Propylene glycol 2.0 Sorbitto 16.0 Sodium carboxymethyl cellulose 1.2 Sodium saccharin 0.05 SDS 2.0 POE hydrogenated castor oil 0.5 Sodium chloride 10.0 Paraben 0.1 Fragrance 1.0 Purified water Balance 100.0% Average number of moles of EO added as POE hydrogenated castor oil 60
moles and 50 moles, 40 moles, 30 moles, 20 moles,
Table 5 shows the results of a paired comparison test conducted by 10 expert panelists on toothpastes using 10 mol of each.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】
第5表−1〜5の結果より、POE(50モル、
40モル、30モル、20モル及び10モル)硬化ヒマシ
油を用いた歯磨はPOE(60モル)硬化ヒマシ油
を用いた歯磨よりもあと味が非常によく、起泡速
度も早くて使用感が優れていることが認められ
た。
第4表の結果より、POE(40モル)硬化ヒマ
シ油を用いた歯磨はPOE(60モル)硬化ヒマシ
油を用いた歯磨よりもあと味が非常によく、起泡
速度も早くて使用感が優れていることが認められ
た。
また、POE硬化ヒマシ油として平均EO付加モ
ル数20モルのものを用いた歯磨(歯磨C)と前記
歯磨Aとを一対比較テストした結果も、同様に歯
磨Cのあと味が良好で使用感が優れていた。
実験例 6
実験例4の歯磨をラミネートチユーブに充填
し、−5℃で1か月保存した後、−5℃においてチ
ユーブからの押出し易さを官能評価した。結果を
第6表に示す。
評価基準
〇:スムーズに押し出せる
△:押出しにやや力を要する
×:押出しに非常に力を要する[Table] From the results in Table 5-1 to 5, POE (50 mol,
Toothpaste using hydrogenated castor oil (40 mol, 30 mol, 20 mol, and 10 mol) has a much better aftertaste than toothpaste using hydrogenated castor oil (POE (60 mol)), has a faster foaming speed, and has a pleasant feeling of use. Recognized as excellent. From the results in Table 4, the toothpaste using POE (40 mol) hydrogenated castor oil has a much better aftertaste than the toothpaste using POE (60 mol) hydrogenated castor oil, has a faster foaming speed, and has a better feeling of use. Recognized as excellent. In addition, the results of a pairwise comparison test of toothpaste A using POE hydrogenated castor oil with an average number of moles of EO addition of 20 moles (toothpaste C) and toothpaste A also revealed that toothpaste C had a good aftertaste and a good feeling of use. It was excellent. Experimental Example 6 The toothpaste of Experimental Example 4 was filled into a laminated tube and stored at -5°C for one month, and then the ease of extrusion from the tube was sensory-evaluated at -5°C. The results are shown in Table 6. Evaluation criteria 〇: Extrudes smoothly △: Requires a little force to extrude ×: Requires a lot of force to extrude
【表】
第6表の結果より、POE(50モル、40モル、
30モル、20モル及び10モル)硬化ヒマシ油を用い
ることによつて低温における押出し性を改善し得
ることが認められた。
以下、実施例を示す。
実施例 1
練歯磨
第2リン酸カルシウム 45.0%
無水ケイ酸 2.0
ソルビツト 18.0
カルボキシメチルセルロースナトリウム 1.2
ラウリル硫酸ナトリウム 1.5
POE(40モル)硬化ヒマシ油 0.5
酢酸トコフエロール 0.2
塩酸クロルヘキシジン 0.01
サツカリンナトリウム 0.15
香料(ペパーミント系) 1.0
パラベン 0.1
精製水 残
計 100.0%
実施例 2
練歯磨
炭酸カルシウム 40.0%
ソルビツト 10.0
グリセリン 10.0
カルボキシメチルセルロースナトリウム 0.5
カラギーナン 0.5
ラウリル硫酸ナトリウム 1.5
POE(30モル)硬化ヒマシ油 1.0
モノフルオロリン酸ナトリウム 0.76
サツカリンナトリウム 0.2
香料(スペアミント系) 1.0
パラベン 0.1
精製水 残
計 100.0%
実施例 3
練歯磨
水酸化アルミニウム 50.0%
無水ケイ酸 2.0
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.0
α−オレフインスルフオン酸ナトリウム 2.0
POE(20モル)硬化ヒマシ油 0.8
グリチルレチン酸 0.03
トラネキサム酸 0.05
サツカリンナトリウム 0.2
香料(スペアミント系) 1.2
パラベン 0.15
精製水 残
計 100.0%
実施例 4
練歯磨
炭酸カルシウム 35.0%
無水ケイ酸 1.5
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.2
ラウリル硫酸ナトリウム 2.0
POE(40モル)硬化ヒマシ油 1.0
塩化ナトリウム 10.0
アラントインクロルヒドロキシアルミニウム
0.1
ε−アミノカプロン酸 0.03
サツカリンナトリウム 0.05
香料(ダブルミント系) 1.0
パラベン 0.05
精製水 残
計 100.0%
実施例 5
練歯磨
第2リン酸カルシウム 40.0%
無水ケイ酸 2.0
ソルビツト 10.0%
グリセリン 6.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 0.6
カラギーナン 0.5
ラウリル硫酸ナトリウム 1.0
POE(40モル)硬化ヒマシ油 0.5
ラウロイルザルコシネート 0.5
グリチルリチンジカリウム 0.1
香料(ペパーミント系) 1.0
パラベン 0.2
精製水 残
計 100.0%
実施例 6
練歯磨
水酸化アルミニウム 45.0%
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.2
ラウリル硫酸ナトリウム 1.8
POE(20モル)硬化ヒマシ油 0.3%
サツカリンナトリウム 0.2
香料(ペパーミント系) 1.2
パラベン 0.1
精製水 残
計 100.0%
実施例 7
練歯磨
沈降性シリカ 25.0%
ソルビツト 10.0
グリセリン 20.0
カルボキシメチルセルロースナトリウム 1.0
ラウリル硫酸ナトリウム 1.5
POE(20モル)硬化ヒマシ油 0.5
クロルヘキシジングルコネート 0.01
モノフルオロリン酸ナトリウム 0.76
サツカリンナトリウム 0.1
香料(ペパーミント系) 1.0
精製水 残
計 100.0%
実施例 8
練歯磨
第2リン酸カルシウム 40.0%
無水ケイ酸 2.0
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.2
ラウリル硫酸ナトリウム 2.0
POE(40モル)硬化ヒマシ油 0.5
塩化ナトリウム 10.0
トラネキサム酸 0.05
酢酸トコフエロール 0.2
サツカリンナトリウム 0.05
香料(スペアミント系) 1.0
パラベン 0.05
精製水 残
計 100.0%
実施例 9
練歯磨
炭酸カルシウム 35.0%
無水ケイ酸 2.0
ソルビツト 10.0%
グリセリン 6.0
カルボキシメチルセルロースナトリウム 0.8
カラギーナン 0.4
ラウリル硫酸ナトリウム 1.5
ラウロイルザルコシネート 0.5
POE(20モル)硬化ヒマシ油 1.0
塩化ナトリウム 5.0
グリチルリチンジカリウム 0.05
グルタミン酸ナトリウム 0.001
香料(ダブルミント系) 1.0
パラベン 0.05
精製水 残
計 100.0%
実施例 10
練歯磨
水酸化アルミニウム 40.0%
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.0
アルギン酸ナトリウム 0.2%
ラウリル硫酸ナトリウム 2.5
POE(40モル)硬化ヒマシ油 1.0
塩化ナトリウム 15.0
ε−アミノカプロン酸 0.03
サツカリンナトリウム 0.05
香 料 1.0
パラベン 0.1
精製水 残
計 100.0%
実施例 11
練歯磨
炭酸カルシウム 45.0%
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.2
α−オレフインスルフオン酸ナトリウム 2.0
POE(20モル)硬化ヒマシ油 0.3
塩化ナトリウム 10.0
グリチルレチン酸 0.02
サツカリンナトリウム 0.05%
香 料 1.0
パラベン 0.1
精製水 残
計 100.0%
実施例 12
練歯磨
第2リン酸カルシウム 35.0%
ソルビツト 8.0
グリセリン 8.0
カルボキシメチルセルロースナトリウム 1.2
ラウリル硫酸ナトリウム 2.0
POE(40モル)硬化ヒマシ油 1.5
塩化ナトリウム 20.0
アラントインクロルヒドロキシアルミニウム
0.1
イノシン酸ナトリウム 0.001
グアニル酸ナトリウム 0.001
サツカリンナトリウム 0.1
香 料 1.0
パラベン 0.05
ラウリン酸ジエタノールアシド 0.5%
精製水 残
計 100.0%
実施例 13
練歯磨
炭酸カルシウム 35.0%
無水ケイ酸 2.0
ソルビツト 16.0
プロピレングリコール 2.0
カルボキシメチルセルロースナトリウム 1.2
ラウリル硫酸ナトリウム 1.8
POE(40モル)硬化ヒマシ油 0.5
塩化ナトリウム 10.0
トラネキサム酸 0.05
アラントインクロルヒドロキシアルミニウム
0.1
サツカリンナトリウム 0.1
香 料 1.0
パラベン 0.05
精製水 残
計 100.0%
実施例1〜13の練歯磨はいずれも使用感が良好
で、液分離が生じ難く、低温押出し性に優れてい
るものである。[Table] From the results in Table 6, POE (50 mol, 40 mol,
It has been found that extrudability at low temperatures can be improved by using hydrogenated castor oil (30 mol, 20 mol and 10 mol). Examples are shown below. Examples 1 Calcium 2 phosphate 45.0 % hydrogy acid 2.0 Sorbitzo 18.0 Calvoxymethylcerous sodium 1.2 laurelil sodium sodium sodium sodium sodium 1.5 PoE (40 moles) hardened hemi oil 0.5 5 コ 酸 酸 酸 酸 酸 酸 酸 酸 0 0 0 0 0 0 0 0 0 0 0 Karin sodium 0.15 fragrance (peppermint system) 1.0 paraben 0.1 Purified water Balance total 100.0% Example 2 Toothpaste calcium carbonate 40.0% Sorbit 10.0 Glycerin 10.0 Sodium carboxymethylcellulose 0.5 Carrageenan 0.5 Sodium lauryl sulfate 1.5 POE (30 mol) Hydrogenated castor oil 1.0 Sodium monofluorophosphate 0.76 Sodium saccharin 0.2 Fragrance (Spearmint type) 1.0 Paraben 0.1 Purified water Balance 100.0% Example 3 Toothpaste aluminum hydroxide 50.0% Silicic anhydride 2.0 Sorbiturate 16.0 Propylene glycol 2.0 Sodium carboxymethyl cellulose 1.0 Sodium α-olefin sulfonate 2.0 POE (20 mol) hardening Castor oil 0.8 Glycyrrhetinic acid 0.03 Tranexamic acid 0.05 Satucalin sodium 0.2 Fragrance (spearmint type) 1.2 Paraben 0.15 Purified water Balance total 100.0% Example 4 Toothpaste calcium carbonate 35.0% Silicic anhydride 1.5 Sorbit 16.0 Propylene glycol 2.0 Carboxymethyl Cellulose Sodium 1.2 Lauryl Sodium sulfate 2.0 POE (40 mol) Hydrogenated castor oil 1.0 Sodium chloride 10.0 Allantoin chlorhydroxyaluminum
0.1 ε -aminocoproponic acid 0.03 Satsukarin sodium 0.05 fragrance (double mint system) 1.0 paraben 0.05 Refined water remaining 100.0 % metropolitan 1.0 % of denture Calvoxymethylcellulose natrium 0.6 Carrageenan 0.5 Sodium lauryl sulfate 1.0 POE (40 mol) Hydrogenated castor oil 0.5 Lauroyl sarcosinate 0.5 Glycyrrhizin dipotassium 0.1 Fragrance (peppermint type) 1.0 Paraben 0.2 Purified water Balance 100.0% Example 6 Toothpaste aluminum hydroxide 45.0% Sorbit 16.0 Propylene glycol 2.0 Sodium carboxymethyl cellulose 1.2 Sodium lauryl sulfate 1.8 POE (20 mol) Hydrogenated castor oil 0.3% Sodium satucalin 0.2 Fragrance (peppermint type) 1.2 Paraben 0.1 Purified water Balance 100.0% Example 7 Precipitated toothpaste silica 25.0% Sorbit 10.0 Glycerin 20.0 Sodium carboxymethyl cellulose 1.0 Sodium lauryl sulfate 1.5 POE (20 mol) Hydrogenated castor oil 0.5 Chlorhexidine gluconate 0.01 Sodium monofluorophosphate 0.76 Sodium saccharin 0.1 Flavor (peppermint type) 1.0 Purified water Remaining amount 100.0% Example 8 Toothpaste dicalcium phosphate 40.0% Silicic anhydride 2.0 Sorbit 16.0 Propylene glycol 2.0 Sodium carboxymethyl cellulose 1.2 Sodium lauryl sulfate 2.0 POE (40 mol) Hydrogenated castor oil 0.5 Sodium chloride 10.0 Tranexamic acid 0.05 Tocopheryl acetate 0.2 Saccharin sodium 0.05 Fragrance (spare) Mint type) 1.0 paraben 0.05 purified water surplus 100.0 % 100.0 % calcium carbonate 35.0 % sorbitzo 2.0 % sorbit 10.0 % sorbit 10.0 % glycirin 6.0 carboximethylcellulose natrium 0.8 Calaginan 0.4 laurelil sodium 1.5 Laurelicocarcocarcean Tate 0.5 PoE (20 mol) hard -cured castor oil 1.0 Sodium chloride 5.0 Glycyrrhizin dipotassium 0.05 Sodium glutamate 0.001 Fragrance (double mint type) 1.0 Paraben 0.05 Purified water Balance total 100.0% Example 10 Toothpaste Aluminum hydroxide 40.0% Sorbit 16.0 Propylene glycol 2.0 Sodium carboxymethyl cellulose 1.0 Sodium alginate 0.2% lauryl sulfate Sodium 2.5 POE (40 mol) Hydrogenated castor oil 1.0 Sodium chloride 15.0 ε-Aminocaproic acid 0.03 Saccharin sodium 0.05 Fragrance 1.0 Paraben 0.1 Purified water Balance 100.0% Example 11 Toothpaste calcium carbonate 45.0% Sorbit 16.0 Propylene glycol 2.0 Carboxymethyl cellulose Sodium 1.2 Sodium α-olefin sulfonate 2.0 POE (20 mol) Hydrogenated castor oil 0.3 Sodium chloride 10.0 Glycyrrhetinic acid 0.02 Sodium saccharin 0.05% Fragrance 1.0 Paraben 0.1 Purified water Balance 100.0% Example 12 Toothpaste dibasic calcium phosphate 35.0 % Sorbit 8.0 Glycerin 8.0 Sodium carboxymethylcellulose 1.2 Sodium lauryl sulfate 2.0 POE (40 mol) hydrogenated castor oil 1.5 Sodium chloride 20.0 Allantoin chlorhydroxyaluminum
0.1 Sodium inosinate 0.001 Sodium guanylate 0.001 Sodium saccharin 0.1 Fragrance 1.0 Paraben 0.05 Lauric diethanolic acid 0.5% Purified water Balance 100.0% Example 13 Toothpaste calcium carbonate 35.0% Silicic anhydride 2.0 Sorbit 16.0 Propylene glycol 2.0 carboxymethylcellulose Sodium 1.2 Sodium lauryl sulfate 1.8 POE (40 mol) hydrogenated castor oil 0.5 Sodium chloride 10.0 Tranexamic acid 0.05 Allantoin chlorohydroxyaluminum
0.1 Satucharin sodium 0.1 Fragrance 1.0 Paraben 0.05 Purified water Balance total 100.0% All of the toothpastes of Examples 1 to 13 have a good feeling of use, are resistant to liquid separation, and have excellent low-temperature extrudability.
Claims (1)
40モル、30モル、20モル及び10モルのポリオキシ
エチレン硬化ヒマシ油から選ばれる少なくとも1
種を組成物全体の0.1〜3重量%含有していると
共に、アルキル基の炭素数8〜18の高級アルキル
硫酸エステルの水溶性塩及び/又はα−オレフイ
ンスルフオン酸の水溶性塩を組成物全体の0.5〜
5重量%含有してなることを特徴とする口腔用組
成物。 2 平均エチレンオキシド付加モル数が50モル、
40モル、30モル、20モル及び10モルのポリオキシ
エチレン硬化ヒマシ油から選ばれる少なくとも1
種を組成物全体の0.1〜3重量%含有していると
共に、アルキル基の炭素数8〜18の高級アルキル
硫酸エステルの水溶性塩及び/又はα−オレフイ
ンスルフオン酸の水溶性塩を組成物全体の0.5〜
5重量%含有し、かつ塩化ナトリウムを配合して
なることを特徴とする口腔用組成物。 3 塩化ナトリウムの配合量が組成物全体の3〜
30重量%である特許請求の範囲第2項記載の口腔
用組成物。[Claims] 1. The average number of moles of ethylene oxide added is 50 moles,
At least one selected from 40 mol, 30 mol, 20 mol and 10 mol polyoxyethylene hydrogenated castor oil
The composition contains a water-soluble salt of a higher alkyl sulfate having an alkyl group of 8 to 18 carbon atoms and/or a water-soluble salt of α-olefin sulfonic acid. Total 0.5~
An oral cavity composition characterized by containing 5% by weight. 2 The average number of moles of ethylene oxide added is 50 moles,
At least one selected from 40 mol, 30 mol, 20 mol and 10 mol polyoxyethylene hydrogenated castor oil
The composition contains a water-soluble salt of a higher alkyl sulfate having an alkyl group of 8 to 18 carbon atoms and/or a water-soluble salt of α-olefin sulfonic acid. Total 0.5~
An oral composition comprising 5% by weight of sodium chloride. 3 The amount of sodium chloride in the entire composition is 3~
30% by weight of the oral composition according to claim 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22860382A JPS59122417A (en) | 1982-12-29 | 1982-12-29 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22860382A JPS59122417A (en) | 1982-12-29 | 1982-12-29 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59122417A JPS59122417A (en) | 1984-07-14 |
| JPS6217966B2 true JPS6217966B2 (en) | 1987-04-21 |
Family
ID=16878936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP22860382A Granted JPS59122417A (en) | 1982-12-29 | 1982-12-29 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59122417A (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0788292B2 (en) * | 1986-09-05 | 1995-09-27 | ライオン株式会社 | Oral composition |
| US5100650A (en) * | 1987-06-30 | 1992-03-31 | Warner-Lambert Company | Anti-bacterial oral composition containing bis-biguanido hexanes |
| JP3520173B2 (en) * | 1996-03-12 | 2004-04-19 | 株式会社資生堂 | Solubilized cosmetic |
| JPH11209255A (en) * | 1997-11-19 | 1999-08-03 | Lion Corp | Toothpaste composition |
| JPH11322554A (en) * | 1998-05-06 | 1999-11-24 | Sunstar Inc | Composition for oral cavity |
| JP4888636B2 (en) * | 2005-12-21 | 2012-02-29 | ライオン株式会社 | Dentifrice composition |
| JP6138538B2 (en) * | 2013-03-25 | 2017-05-31 | サンスター株式会社 | Transparent liquid composition for oral cavity |
| JP6834978B2 (en) * | 2015-11-30 | 2021-02-24 | ライオン株式会社 | Toothpaste composition and oral biofilm remover |
| JP7218327B2 (en) * | 2020-06-18 | 2023-02-06 | 花王株式会社 | oral composition |
-
1982
- 1982-12-29 JP JP22860382A patent/JPS59122417A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59122417A (en) | 1984-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1040819B1 (en) | Oral compositions comprising a potassium salt for reducing dental nerve and dentin sensitivity | |
| JP3285452B2 (en) | Toothpaste composition | |
| JPS58118509A (en) | Oral composition | |
| JP5790455B2 (en) | Dentifrice composition | |
| JPS6217966B2 (en) | ||
| JP3894132B2 (en) | Dentifrice composition | |
| JPH07145027A (en) | Anhydrous toothpaste composition | |
| JP2586896B2 (en) | Oral composition | |
| JPS6136210A (en) | Oral composition | |
| JP2682020B2 (en) | Oral composition | |
| JP3241922B2 (en) | Oral composition | |
| JPS6217967B2 (en) | ||
| JP3824078B2 (en) | Toothpaste composition | |
| JP2003212741A (en) | Toothpaste composition | |
| JP3107920B2 (en) | Manufacturing method of dentifrice | |
| JPH11130648A (en) | Oral composition | |
| JP2004083543A (en) | Oral composition containing ascorbic acid derivative | |
| JP2018203714A (en) | Oral composition | |
| JP2002212041A (en) | Composition for oral cavity | |
| WO2020016926A1 (en) | Nonaqueous composition for oral cavity | |
| JP3491027B2 (en) | Oral composition | |
| JPS61126011A (en) | Composition for oral cavity application | |
| JP2001163743A (en) | Dentifrice composition | |
| JPH08175942A (en) | Toothpaste composition and evaluation method thereof | |
| JP3195150B2 (en) | Oral composition |